US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ceribell

16.09

-0.2700-1.65%

Pre-market: 16.640.5500+3.42%09:01 EDT

Volume:147.72K

Turnover:2.37M

Market Cap:577.12M

PE:-4.75

High:16.35

Open:16.20

Low:15.60

Close:16.36

Loading ...

Overview Company News Filings

Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference

CeriBell Gets FedRAMP High Authorization for EEG System

MT Newswires Live

BRIEF-Ceribell Says EEG System Receives FedRAMP High Authorization

Ceribell Inc - Eeg System Receives Fedramp High Authorization

THOMSON REUTERS

Ceribell Receives FedRAMP® High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems

Ceribell to Report First Quarter 2025 Financial Results on May 8, 2025

Ceribell, Inc.: Promising Growth Trajectory and Strong Market Potential Reinforce Buy Rating

CBLL Stock Falls Despite FDA Clearance for Pediatric Clarity Algorithm

CeriBell Says FDA Clears Electrographic Seizure Detection Algorithm

MT Newswires Live

BRIEF-FDA Clears Ceribell’S Clarity Algorithm For Pediatric Patients

FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older

THOMSON REUTERS

FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older

Top Midday Gainers

MT Newswires Live

Ceribell jumps after saying no impact from incremental tariffs until Q4

CeriBell Shares Jump After Claiming Inventory in US Provides Buffer From Tariffs Until Q4

MT Newswires Live

With 49% stake, CeriBell, Inc. (NASDAQ:CBLL) seems to have captured institutional investors' interest

Simply Wall St.

CeriBell Initiated at Buy by Ladenburg Thalmann

Ladenburg Thalmann Initiates CeriBell at Buy With $32 Price Target

MT Newswires Live

Ceribell initiated with a Buy at Ladenburg

Ceribell, Inc. Announces Executive Compensation Adjustments

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CBLL/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CBLL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CBLL\",,,,,undefined,":{"symbol":"CBLL","market":"US","secType":"STK","nameCN":"Ceribell","latestPrice":16.09,"timestamp":1746043200000,"preClose":16.36,"halted":0,"volume":147716,"hourTrading":{"tag":"盘前","latestPrice":16.64,"preClose":16.09,"latestTime":"09:01 EDT","volume":5,"amount":83.2,"timestamp":1746104510407},"delay":0,"floatShares":21937409,"shares":35868339,"eps":-3.385363,"marketStatus":"Pre-Mkt","change":-0.27,"latestTime":"05-01 09:07:19 EDT","open":16.2,"high":16.35,"low":15.6,"amount":2372212.442019,"amplitude":0.045844,"askPrice":21.31,"askSize":100,"bidPrice":11.31,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.385363,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1746106200000},"marketStatusCode":1,"adr":0,"listingDate":1728619200000,"exchange":"NASDAQ","adjPreClose":16.09,"preHourTrading":{"tag":"盘前","latestPrice":16.64,"preClose":16.09,"latestTime":"09:01 EDT","volume":5,"amount":83.2,"timestamp":1746104510407},"postHourTrading":{"tag":"盘后","latestPrice":16.09,"preClose":16.09,"latestTime":"16:22 EDT","volume":2069,"amount":33290.21,"timestamp":1746044521018},"volumeRatio":0.44894436642674973,"impliedVol":0.8405,"impliedVolPercentile":0.6889},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CBLL\",,,,,undefined,":{"symbol":"CBLL","floatShares":21937409,"roa":"-17.46%","roe":"-35.75%","lyrEps":-3.385363,"volumeRatio":0.44894436642674973,"shares":35868339,"dividePrice":0,"high":16.35,"amplitude":0.045844,"preClose":16.36,"low":15.6,"week52Low":10.01,"pbRate":"3.02","psRate":"8.82","week52High":32.7489,"institutionHeld":0,"latestPrice":16.09,"eps":-3.385363,"divideRate":0,"volume":147716,"delay":0,"ttmEps":-3.385363,"open":16.2,"prevYearClose":25.88,"prevWeekClose":15.31,"prevMonthClose":16.09,"prevQuarterClose":19.21,"fiveDayClose":15.08,"twentyDayClose":18.77,"sixtyDayClose":23.17,"earningDate":1746633600000,"earningTime":"盘后"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CBLL\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532809611","title":"Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2532809611","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532809611?lang=en_us&edition=fundamental","pubTime":"2025-05-01 04:05","pubTimestamp":1746043500,"startTime":"0","endTime":"0","summary":"SUNNYVALE, Calif., April 30, 2025  -- CeriBell, Inc.  , a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Jane Chao, Ph.D., CEO and Co-founder,will present at the upcoming Bank of America Securities 2025 Health Care Conference. The presentation will take place on Wednesday, May 14, 2025, at 10:55 a.m. Pacific Standard Time / 1:55 p.m. Eastern Standard Time.Event: Bank of America Securities 2025 Health Care ConferenceDate: Wednesday, May 14, 2025Time: 10:55 a.m. PST/ 1:55p.m. EST","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ceribell-participate-bank-america-securities-200500180.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BAC","LU1506573853.SGD","LU1880398471.USD","BK4585","LU0234572021.USD","LU1363072403.SGD","LU0070302665.USD","LU1791807156.HKD","BK4207","BK4559","LU0128525689.USD","IE00B1BXHZ80.USD","LU0256863902.USD","LU0321505868.SGD","LU0648001328.SGD","LU0208291251.USD","LU2129689431.USD","LU0130518102.USD","LU0170899867.USD","BK4082","IE00BLSP4452.SGD","IE00BBT3K403.USD","LU1496350502.SGD","IE00B7SZLL34.SGD","IE00BKVL7J92.USD","LU1718418525.SGD","LU1496350171.SGD","LU1201861249.SGD","LU1162221912.USD","LU1880398554.USD","IE00B19Z3B42.SGD","IE0002270589.USD","IE00BZ1G4Q59.USD","LU0256863811.USD","LU1366192091.USD","IE00B19Z3581.USD","LU0130102774.USD","LU0980610538.SGD","LU0106831901.USD","LU0640476718.USD","BK4588","CBLL","LU1074936037.SGD","BK4581","LU2129689605.HKD","LU0310800965.SGD","BK4534","LU0052756011.USD","LU0098860793.USD","LU1668664300.SGD"],"gpt_icon":0},{"id":"2531052894","title":"CeriBell Gets FedRAMP High Authorization for EEG System","url":"https://stock-news.laohu8.com/highlight/detail?id=2531052894","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531052894?lang=en_us&edition=fundamental","pubTime":"2025-04-30 22:58","pubTimestamp":1746025094,"startTime":"0","endTime":"0","summary":"CeriBell (CBLL) said Wednesday its point-of-care electroencephalogram system has received full Federal Risk & Authorization Management Program, or FedRAMP, High authorization from the US government, w","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4082","CBLL"],"gpt_icon":0},{"id":"2531031350","title":"BRIEF-Ceribell Says EEG System Receives FedRAMP High Authorization","url":"https://stock-news.laohu8.com/highlight/detail?id=2531031350","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531031350?lang=en_us&edition=fundamental","pubTime":"2025-04-30 20:12","pubTimestamp":1746015154,"startTime":"0","endTime":"0","summary":"BRIEF-Ceribell Says EEG System Receives FedRAMP High AuthorizationApril 30 (Reuters) - CeriBell Inc CBLL.O:CERIBELL INC - EEG SYSTEM RECEIVES FEDRAMP HIGH AUTHORIZATIONSource text: ID:nGNX6hp8ZrFurther company coverage: CBLL.O ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nFWN3R82C6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBLL","BK4082"],"gpt_icon":0},{"id":"2531031331","title":"Ceribell Inc - Eeg System Receives Fedramp High Authorization","url":"https://stock-news.laohu8.com/highlight/detail?id=2531031331","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531031331?lang=en_us&edition=fundamental","pubTime":"2025-04-30 20:11","pubTimestamp":1746015071,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nFWN3R82C6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","CBLL"],"gpt_icon":0},{"id":"2531031254","title":"Ceribell Receives FedRAMP® High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems","url":"https://stock-news.laohu8.com/highlight/detail?id=2531031254","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531031254?lang=en_us&edition=fundamental","pubTime":"2025-04-30 20:00","pubTimestamp":1746014400,"startTime":"0","endTime":"0","summary":"Ceribell is one of only 51 companies in the U.S. to achieve FedRAMP High authorization. Ceribell's breakthrough technology can now be deployed in federal healthcare facilities, including U.S. Department of Veterans Affairs hospitals, helping clinicians deliver faster diagnosis and treatment for patients at risk of non-convulsive seizures. With FedRAMP High authorization, Ceribell’s secure, cloud-based solution can be adopted across federal healthcare systems, expanding access to rapid diagnosis of non-convulsive seizures for U.S. veterans and other high-risk patients.FedRAMP is the federal government’s standardized approach to assessing the security of cloud-based systems. The FedRAMP High authorization status represents the highest level of security within this framework, with rigorous requirements for protecting sensitive data, including patient health information. As of April 2025, fewer than 15% of FedRAMP Authorized","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ceribell-receives-fedramp-high-authorization-120000308.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2362541273.HKD","US5Y.BOND","CBLL","US30Y.BOND","US2Y.BOND","US12M.BOND","BK4082","US7Y.BOND","BK4585","LU2362540622.SGD","US6M.BOND","ATO","BK4197","BK4588","LU2362541513.USD","US10Y.BOND","BK4137","US3Y.BOND","HCSG"],"gpt_icon":0},{"id":"2530399699","title":"Ceribell to Report First Quarter 2025 Financial Results on May 8, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2530399699","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530399699?lang=en_us&edition=fundamental","pubTime":"2025-04-25 04:05","pubTimestamp":1745525100,"startTime":"0","endTime":"0","summary":"SUNNYVALE, Calif., April 24, 2025  -- CeriBell, Inc.  , a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that it will release financial results for the first quarter of 2025 after the close of trading on Thursday, May 8, 2025. Company management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET on May 8, 2025.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ceribell-report-first-quarter-2025-200500629.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CBLL","BK4082"],"gpt_icon":0},{"id":"2529813352","title":"Ceribell, Inc.: Promising Growth Trajectory and Strong Market Potential Reinforce Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2529813352","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529813352?lang=en_us&edition=fundamental","pubTime":"2025-04-21 08:25","pubTimestamp":1745195141,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Josh Jennings has reiterated their bullish stance on CBLL stock, giving a Buy rating on April 11. Josh Jennings has given his Buy ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/ceribell-inc-promising-growth-trajectory-and-strong-market-potential-reinforce-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/ceribell-inc-promising-growth-trajectory-and-strong-market-potential-reinforce-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CBLL"],"gpt_icon":0},{"id":"2528222709","title":"CBLL Stock Falls Despite FDA Clearance for Pediatric Clarity Algorithm","url":"https://stock-news.laohu8.com/highlight/detail?id=2528222709","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528222709?lang=en_us&edition=fundamental","pubTime":"2025-04-16 22:40","pubTimestamp":1744814400,"startTime":"0","endTime":"0","summary":"With this clearance, Ceribell strengthens its position in the neurodiagnostic space by addressing a critical gap in pediatric care. The Clarity algorithm is designed to support timely clinical decisions, improve patient outcomes and streamline care in emergency and ICU settings.The Clarity algorithm is a next-generation AI-powered tool designed to work seamlessly with Ceribell’s portable EEG system. It is the first and only FDA-cleared seizure detection algorithm that covers patients from one year of age through adulthood. This wide coverage allows hospitals to use a single system across both pediatric and adult populations, enhancing workflow efficiency and standardizing care. The algorithm was validated using EEG data from more than 1,700 patients, making it the largest dataset ever used for FDA clearance of a s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cbll-stock-falls-despite-fda-144000340.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2720916845.USD","BK4613","LU1989764748.USD","ANGO","LU1989764664.SGD","LU0240877869.USD","BK4534","LU0170899867.USD","LU2764263039.SGD","BK4585","LU0058720904.USD","BK4504","LU0289739699.SGD","BK4082","MASI","BK4167","LU0266013472.USD","LU0205193047.USD","BK4588","VEEV","LU2764263203.CNY","BK4528","CBLL","LU0205194284.USD","LU0240878834.USD","LU2764262908.HKD"],"gpt_icon":0},{"id":"2527412547","title":"CeriBell Says FDA Clears Electrographic Seizure Detection Algorithm","url":"https://stock-news.laohu8.com/highlight/detail?id=2527412547","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527412547?lang=en_us&edition=fundamental","pubTime":"2025-04-15 21:29","pubTimestamp":1744723756,"startTime":"0","endTime":"0","summary":"CeriBell (CBLL) said Tuesday its Clarity algorithm has received 510(k) clearance from the US Food and Drug Administration for the detection of electrographic seizures in patients aged at least one.The","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4082","CBLL"],"gpt_icon":0},{"id":"2527414230","title":"BRIEF-FDA Clears Ceribell’S Clarity Algorithm For Pediatric Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2527414230","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527414230?lang=en_us&edition=fundamental","pubTime":"2025-04-15 21:26","pubTimestamp":1744723591,"startTime":"0","endTime":"0","summary":"BRIEF-FDA Clears Ceribell’S Clarity Algorithm For Pediatric PatientsApril 15 (Reuters) - CeriBell Inc CBLL.O:FDA CLEARS CERIBELL’S CLARITY ALGORITHM FOR PEDIATRIC PATIENTS, MAKING CERIBELL THE FIRST A","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nFWN3QT0LF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBLL","BK4082"],"gpt_icon":0},{"id":"2527490440","title":"FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older","url":"https://stock-news.laohu8.com/highlight/detail?id=2527490440","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527490440?lang=en_us&edition=fundamental","pubTime":"2025-04-15 20:01","pubTimestamp":1744718495,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nFWN3QT0LF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CBLL","BK4082"],"gpt_icon":0},{"id":"2527011412","title":"FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older","url":"https://stock-news.laohu8.com/highlight/detail?id=2527011412","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527011412?lang=en_us&edition=fundamental","pubTime":"2025-04-15 20:00","pubTimestamp":1744718400,"startTime":"0","endTime":"0","summary":"Powered by Clarity, the Ceribell System will enable rapid, bedside detection, diagnosis and treatment of non-convulsive seizures in children experiencing neurological emergencies. FDA clearance of Ceribell’s Clarity algorithm will enable rapid, bedside detection, diagnosis, and treatment of non-convulsive seizures in children experiencing neurological emergencies.\"We believe this clearance will have a profound impact on the lives of critically ill children, who are particularly vulnerable to preventable brain injury,\" said Jane Chao, Ph.D., co-founder and CEO of Ceribell. \"It is well understood that seizures can lead to poor clinical outcomes when not treated in a timely manner. Yet, until now, clinicians have never had access to point-of-care EEG with a seizure detection algorithm tailored specifically for pediatric patients as young as 1 year old. This breakthrough, which we expect to be commercially available soon, marks another important step toward our mission of making rapid EEG ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fda-clears-ceribell-clarity-algorithm-120000953.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CBLL","BK4082"],"gpt_icon":0},{"id":"2526461466","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2526461466","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526461466?lang=en_us&edition=fundamental","pubTime":"2025-04-12 02:25","pubTimestamp":1744395915,"startTime":"0","endTime":"0","summary":"MSP Recovery (MSPR) shares surged 90% after the company said late Thursday that it agreed to a term sheet for several restructuring deals with Hazel Partners, Virage Capital Management, and their affi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","THTX","BK4196","BK4082","MSPR","CBLL"],"gpt_icon":0},{"id":"2526619916","title":"Ceribell jumps after saying no impact from incremental tariffs until Q4","url":"https://stock-news.laohu8.com/highlight/detail?id=2526619916","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526619916?lang=en_us&edition=fundamental","pubTime":"2025-04-12 01:40","pubTimestamp":1744393214,"startTime":"0","endTime":"0","summary":"Shares of Ceribell (CBLL) are soaring in Friday trading after the company said in an 8K filing that it expects no material impact to its financial ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ceribell-jumps-after-saying-no-impact-from-incremental-tariffs-until-q4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ceribell-jumps-after-saying-no-impact-from-incremental-tariffs-until-q4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CBLL","BK4082"],"gpt_icon":0},{"id":"2526616105","title":"CeriBell Shares Jump After Claiming Inventory in US Provides Buffer From Tariffs Until Q4","url":"https://stock-news.laohu8.com/highlight/detail?id=2526616105","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526616105?lang=en_us&edition=fundamental","pubTime":"2025-04-12 01:37","pubTimestamp":1744393043,"startTime":"0","endTime":"0","summary":"CeriBell  shares jumped over 34% in recent trading Friday after the company disclosed it was insulated from Trump tariffs until at least Q4.The company sources manufacturing and assembly of its headband product from two vendors in China, with final quality inspection and packaging taking place in California, it said.CeriBell said it had enough supply of finished headband products to last through at least Q3.\"Because the company accounts for product inventory cost of goods sold on a first-in, first-out basis, the company does not expect any material impact to its financial results from incremental tariffs until at least [Q4] 2025,\" CeriBell said in a regulatory filing.Once the current inventory of finished goods is sold, CeriBell expects the impact to its total gross margins by 8 to 10 percentage points, based on the current tariff of 145% on all imports from China.The company's total gross margin recorded for the year ended Dec. 31, 2024, was 87%, it said.Price: 14.98, Change: +3.83, P","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4082","CBLL"],"gpt_icon":0},{"id":"2526472599","title":"With 49% stake, CeriBell, Inc. (NASDAQ:CBLL) seems to have captured institutional investors' interest","url":"https://stock-news.laohu8.com/highlight/detail?id=2526472599","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526472599?lang=en_us&edition=fundamental","pubTime":"2025-04-10 22:08","pubTimestamp":1744294102,"startTime":"0","endTime":"0","summary":"Institutions' substantial holdings in CeriBell implies that they have significant influence over the company's share price. 51% of the business is held by the top 6 shareholders. Using data from  analyst forecasts alongside ownership research, one can better assess the future performance of a company. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.If you want to know who really controls CeriBell, Inc. , then you'll have to look at the makeup of its share registry. With 49% stake, institutions possess the maximum shares in the company. Put another way, the group faces the maximum upside potential .Because institutional owners have a huge pool of resources and liquidity, their investing decisions tend to carry a great deal of weight, especially with individual investors. As a result, a sizeable amount of institutional money invested in a firm is generally viewed as a positive attribute.Let's take a closer look to see what t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/49-stake-ceribell-inc-nasdaq-140822891.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["USJW.SI","LU2095319765.USD","LU2210150020.SGD",".IXIC","BK4082","MNQmain","QID","NDAQ","BK4585","QLD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","TQQQ","BK4112","IE00B64PRP62.GBP","TSYW.SI","LU2210149790.SGD","USAW.SI","SQQQ","PSQ","NQmain","IE00BGHQF748.EUR","CBLL","NVIW.SI","BK4588"],"gpt_icon":1},{"id":"2524209836","title":"CeriBell Initiated at Buy by Ladenburg Thalmann","url":"https://stock-news.laohu8.com/highlight/detail?id=2524209836","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524209836?lang=en_us&edition=fundamental","pubTime":"2025-04-04 20:24","pubTimestamp":1743769440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CBLL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 04, 2025 08:24 ET (12:24 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBLL","BK4082"],"gpt_icon":0},{"id":"2524208703","title":"Ladenburg Thalmann Initiates CeriBell at Buy With $32 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2524208703","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524208703?lang=en_us&edition=fundamental","pubTime":"2025-04-04 19:20","pubTimestamp":1743765619,"startTime":"0","endTime":"0","summary":"CeriBell (CBLL) has an average rating of buy and mean price target of $33, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and res","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CBLL"],"gpt_icon":0},{"id":"2524720887","title":"Ceribell initiated with a Buy at Ladenburg","url":"https://stock-news.laohu8.com/highlight/detail?id=2524720887","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524720887?lang=en_us&edition=fundamental","pubTime":"2025-04-04 18:40","pubTimestamp":1743763223,"startTime":"0","endTime":"0","summary":"Ladenburg initiated coverage of Ceribell (CBLL) with a Buy rating and $32 price target The company has a first-mover advantage in scaling rapid ele...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ceribell-initiated-with-a-buy-at-ladenburg?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ceribell-initiated-with-a-buy-at-ladenburg?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","CBLL"],"gpt_icon":0},{"id":"2519312403","title":"Ceribell, Inc. Announces Executive Compensation Adjustments","url":"https://stock-news.laohu8.com/highlight/detail?id=2519312403","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519312403?lang=en_us&edition=fundamental","pubTime":"2025-03-15 03:17","pubTimestamp":1741979858,"startTime":"0","endTime":"0","summary":"An update from Ceribell, Inc. ( ($CBLL) ) is now available. On March 10, 2025, Ceribell, Inc. announced adjustments to the compensation packages of...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ceribell-inc-announces-executive-compensation-adjustments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ceribell-inc-announces-executive-compensation-adjustments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CBLL","BK4082"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":77,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CBLL\",params:#limit:5,,,undefined,":[{"date":"2025-05-08","symbol":"CBLL","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":-0.43,"defaultRemindTime":1746734400000,"name":null,"time":"Post Market","dateTimestamp":1746676800000,"actualEps":null},{"market":"US","date":"2025-02-25","symbol":"CBLL","fiscalQuarterEnding":"2024/12","expectedEps":-0.32,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740459600000,"reportTimeType":"post","actualEps":-0.4},{"market":"US","date":"2024-11-12","symbol":"CBLL","fiscalQuarterEnding":"2024/09","expectedEps":-0.82,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-1.85}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CBLL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CBLL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":6,"updateTime":1743825600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CBLL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CBLL","date":"2025-04-30","current":-14.505155,"percent":0.911765,"low":-31.439367,"twenty":-28.235701,"median":-22.810668,"eighty":-17.99845,"high":-9.885848,"avg":-22.770305,"sd":5.112993,"marketCap":586806026},"quantilePoints":[{"date":"2024-10-11","current":-17.636997,"twenty":-17.222009,"median":-16.599526,"eighty":-15.977044,"marketCap":578317118},{"date":"2024-10-18","current":-27.492965,"twenty":-27.233597,"median":-26.455495,"eighty":-19.29695,"marketCap":901494331},{"date":"2024-10-25","current":-28.702676,"twenty":-28.6853,"median":-27.456654,"eighty":-26.040507,"marketCap":941160750},{"date":"2024-10-31","current":-28.246561,"twenty":-28.615797,"median":-28.219411,"eighty":-26.455495,"marketCap":926204733},{"date":"2024-11-08","current":-31.439367,"twenty":-28.963313,"median":-28.463759,"eighty":-26.486619,"marketCap":1030896848},{"date":"2024-11-15","current":-27.13588,"twenty":-29.27825,"median":-28.458329,"eighty":-27.13588,"marketCap":981043460},{"date":"2024-11-22","current":-25.000572,"twenty":-28.963313,"median":-28.246561,"eighty":-25.93676,"marketCap":903845676},{"date":"2024-11-29","current":-28.528199,"twenty":-28.754803,"median":-28.246561,"eighty":-26.043953,"marketCap":1031379984},{"date":"2024-12-06","current":-28.022837,"twenty":-28.754803,"median":-28.33145,"eighty":-26.11912,"marketCap":1013109620},{"date":"2024-12-13","current":-28.934471,"twenty":-29.290749,"median":-28.463759,"eighty":-26.390638,"marketCap":1046067924},{"date":"2024-12-20","current":-26.486932,"twenty":-29.217263,"median":-28.434619,"eighty":-26.480394,"marketCap":957582042},{"date":"2024-12-27","current":-26.239205,"twenty":-29.058794,"median":-28.293244,"eighty":-26.474169,"marketCap":948625981},{"date":"2025-01-03","current":-25.624843,"twenty":-28.959703,"median":-28.107549,"eighty":-26.162518,"marketCap":926414949},{"date":"2025-01-10","current":-22.810668,"twenty":-28.950325,"median":-27.629083,"eighty":-25.703081,"marketCap":824674096},{"date":"2025-01-17","current":-19.966767,"twenty":-28.888112,"median":-27.428293,"eighty":-25.067954,"marketCap":721858516},{"date":"2025-01-24","current":-22.860214,"twenty":-28.702676,"median":-27.180566,"eighty":-24.06912,"marketCap":826465309},{"date":"2025-01-31","current":-23.583576,"twenty":-28.691816,"median":-26.734658,"eighty":-23.038577,"marketCap":852617007},{"date":"2025-02-07","current":-22.404397,"twenty":-28.676835,"median":-26.675204,"eighty":-22.810668,"marketCap":809986156},{"date":"2025-02-14","current":-21.700853,"twenty":-28.676835,"median":-26.471057,"eighty":-22.741305,"marketCap":784550943},{"date":"2025-02-21","current":-22.89985,"twenty":-28.628005,"median":-26.224342,"eighty":-22.412324,"marketCap":827898278},{"date":"2025-02-28","current":-21.066166,"twenty":-28.554982,"median":-26.070751,"eighty":-22.392506,"marketCap":852231734},{"date":"2025-03-07","current":-19.700766,"twenty":-28.530515,"median":-25.634752,"eighty":-21.924596,"marketCap":796994492},{"date":"2025-03-14","current":-18.973735,"twenty":-28.528199,"median":-25.33748,"eighty":-21.562126,"marketCap":767582454},{"date":"2025-03-21","current":-17.971851,"twenty":-28.50271,"median":-25.099663,"eighty":-21.066166,"marketCap":727051231},{"date":"2025-03-28","current":-17.581737,"twenty":-28.470275,"median":-24.772663,"eighty":-20.685126,"marketCap":711269162},{"date":"2025-04-04","current":-16.606451,"twenty":-28.455071,"median":-23.826348,"eighty":-20.087337,"marketCap":671813989},{"date":"2025-04-11","current":-9.885848,"twenty":-28.423651,"median":-23.117849,"eighty":-19.576639,"marketCap":399931979},{"date":"2025-04-17","current":-12.847169,"twenty":-28.370492,"median":-23.028668,"eighty":-18.81521,"marketCap":519732232},{"date":"2025-04-25","current":-13.733792,"twenty":-28.283907,"median":-22.880032,"eighty":-18.236951,"marketCap":555600571},{"date":"2025-04-30","current":-14.505155,"twenty":-28.235701,"median":-22.810668,"eighty":-17.99845,"marketCap":586806026}],"updateTime":1746104839330}}}